| NDC Number | Brand Name | Generic Name | Manufacturer | Dosage Form | DEA Sch. | Marketing Start Date |
|---|---|---|---|---|---|---|
| 25682-001 | SOLIRIS | ECULIZUMAB | Alexion Pharmaceuticals Inc. | INJECTION, SOLUTION, CONCENTRATE | 2007-04-02 | |
| 25682-022 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | SOLUTION, CONCENTRATE | 2018-12-21 | |
| 25682-025 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | SOLUTION, CONCENTRATE | 2020-10-09 | |
| 25682-028 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | SOLUTION, CONCENTRATE | 2020-10-09 | |
| 50474-990 | ZILBRYSQ | zilucoplan | UCB, Inc. | INJECTION, SOLUTION | 2024-01-03 | |
| 50474-991 | ZILBRYSQ | zilucoplan | UCB, Inc. | INJECTION, SOLUTION | 2024-01-03 | |
| 50474-992 | ZILBRYSQ | zilucoplan | UCB, Inc. | INJECTION, SOLUTION | 2024-01-03 | |
| 51759-208 | EPYSQLI | Eculizumab-aagh | Teva Pharmaceuticals USA, Inc. | INJECTION, SOLUTION | 2025-04-07 | |
| 55513-180 | BKEMV | eculizumab-aeeb | Amgen Inc | INJECTION, SOLUTION, CONCENTRATE | 2025-03-01 | |
| 61755-014 | VEOPOZ | Pozelimab | Regeneron Pharmaceuticals, Inc. | INJECTION, SOLUTION | 2023-08-18 | |
| 73606-010 | Empaveli | Pegcetacoplan | Apellis Pharmaceuticals, Inc. | INJECTION, SOLUTION | 2021-05-14 | |
| 73606-020 | Syfovre | Pegcetacoplan | Apellis Pharmaceuticals, Inc. | INJECTION, SOLUTION | 2023-02-17 |
Loading full table content...